ST Pharm Co.,Ltd. (237690.KQ)

KRW 79400.0

(0.51%)

Long Term Debt Summary of ST Pharm Co.,Ltd.

ST Pharm Co.,Ltd.'s latest annual long term debt in 2023 was 159.68 Billion KRW , up 855.84% from previous year.
ST Pharm Co.,Ltd.'s latest quarterly long term debt in 2024 Q1 was 151.86 Billion KRW , down -4.9% from previous quarter.
ST Pharm Co.,Ltd. reported annual long term debt of 16.7 Billion KRW in 2022, down -81.73% from previous year.
ST Pharm Co.,Ltd. reported annual long term debt of 91.45 Billion KRW in 2021, down -27.22% from previous year.
ST Pharm Co.,Ltd. reported quarterly long term debt of 151.86 Billion KRW for 2024 Q1, down -4.9% from previous quarter.
ST Pharm Co.,Ltd. reported quarterly long term debt of 12.49 Billion KRW for 2023 Q2, down -14.52% from previous quarter.

Annual Long Term Debt Chart of ST Pharm Co.,Ltd. (2023 - 2015)

Historical Annual Long Term Debt of ST Pharm Co.,Ltd. (2023 - 2015)

Year	Long Term Debt	Long Term Debt Growth
2023	159.68 Billion KRW	855.84%
2022	16.7 Billion KRW	-81.73%
2021	91.45 Billion KRW	-27.22%
2020	125.64 Billion KRW	733.31%
2019	15.07 Billion KRW	15364.62%
2018	97.5 Million KRW	-16.67%
2017	117 Million KRW	-14.29%
2016	136.5 Million KRW	-98.66%
2015	10.15 Billion KRW	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	117.5 Billion KRW	-22.63%
2024 Q1	151.86 Billion KRW	-4.9%
2023 Q2	12.49 Billion KRW	-14.52%
2023 Q4	159.68 Billion KRW	99.22%
2023 FY	159.68 Billion KRW	855.84%
2023 Q1	14.62 Billion KRW	-12.47%
2023 Q3	80.15 Billion KRW	541.26%
2022 Q3	105.94 Billion KRW	0.7%
2022 FY	16.7 Billion KRW	-81.73%
2022 Q4	16.7 Billion KRW	-84.23%
2022 Q2	105.21 Billion KRW	14.16%
2022 Q1	92.15 Billion KRW	0.77%
2021 Q4	91.45 Billion KRW	-27.88%
2021 Q1	126.36 Billion KRW	0.26%
2021 Q2	126.4 Billion KRW	0.04%
2021 Q3	126.79 Billion KRW	0.31%
2021 FY	91.45 Billion KRW	-27.22%
2020 Q1	15.46 Billion KRW	-0.53%
2020 FY	125.64 Billion KRW	733.31%
2020 Q4	126.03 Billion KRW	719.21%
2020 Q3	15.38 Billion KRW	-1.49%
2020 Q2	15.61 Billion KRW	0.96%
2019 Q2	157.84 Million KRW	-14.45%
2019 Q3	128.32 Million KRW	-18.7%
2019 Q4	15.55 Billion KRW	12018.65%
2019 Q1	184.5 Million KRW	89.23%
2019 FY	15.07 Billion KRW	15364.62%
2018 Q1	117 Million KRW	0.0%
2018 FY	97.5 Million KRW	-16.67%
2018 Q3	- KRW	-100.0%
2018 Q2	117 Million KRW	0.0%
2018 Q4	97.5 Million KRW	0.0%
2017 Q2	136.5 Million KRW	0.0%
2017 Q1	136.5 Million KRW	0.0%
2017 Q4	117 Million KRW	0.0%
2017 FY	117 Million KRW	-14.29%
2017 Q3	- KRW	-100.0%
2016 Q4	136.5 Million KRW	0.0%
2016 Q2	20.15 Billion KRW	0.0%
2016 Q1	- KRW	-100.0%
2016 Q3	136.5 Million KRW	-99.32%
2016 FY	136.5 Million KRW	-98.66%
2015 FY	10.15 Billion KRW	0.0%
2015 Q4	10.15 Billion KRW	0.0%

Peer Long Term Debt Comparison of ST Pharm Co.,Ltd.

Name	Long Term Debt	Long Term Debt Difference
Sam Chun Dang Pharm. Co., Ltd	16 Billion KRW	-898.055%
Hyundai Bioscience Co., Ltd.	32.43 Million KRW	-492280.546%
ABL Bio Inc.	43 Billion KRW	-271.369%
Cellid, Co., Ltd.	6.48 Billion KRW	-2361.588%